Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lectin Deficiency

Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency

Abstract

Summary:

It has been reported that in allogeneic stem cell transplantation, the mannan-binding lectin (MBL) status of the donor has prognostic value for the recipient. Two MBL-deficient patients, with coexisting haematological malignancy, were identified who were treated with bone marrow from donors with normal MBL concentrations. Although both patients engrafted successfully and remain in complete remission, neither seroconverted to the MBL sufficiency status of his donor over a follow-up period exceeding 2 years. This does not support the concept of MBL replacement by stem cell therapy, and does not provide an explanation for high MBL concentrations in stem cell donors protecting recipients from post transplant infections.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kilpatrick DC . Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401–413.

    Article  CAS  Google Scholar 

  2. Kilpatrick DC . Mannan-binding lectin and its role in innate immunity. Transfus Med 2002; 12: 335–352.

    Article  CAS  Google Scholar 

  3. Turner MW . The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40: 423–429.

    Article  CAS  Google Scholar 

  4. Valdimarsson H, Vikingsdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59: 97–102.

    Article  CAS  Google Scholar 

  5. Jensenius JC, Jensen PH, McGuire K et al. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003; 31: 763–767.

    Article  CAS  Google Scholar 

  6. Mullighan CG, Heatley S, Doherty K et al. Mannose binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524–3529.

    Article  CAS  Google Scholar 

  7. Mullighan CG, Bardy PG . Mannose-binding lectin and infection following allogeneic hemopoietic stem cell transplantation. Leukemia Lymphoma 2004; 45: 247–256.

    Article  CAS  Google Scholar 

  8. Downing I, Koch C, Kilpatrick DC . Immature dendritic cells possess a sugar-sensitive receptor for human mannan-binding lectin. Immunology 2003; 109: 360–364.

    Article  CAS  Google Scholar 

  9. Kilpatrick DC, McLintock LA, Allan EK et al. No strong relationship between mannan-binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003; 134: 279–284.

    Article  CAS  Google Scholar 

  10. Kilpatrick DC . Mannan binding protein in sera positive for rheumatoid factor. Br J Rheumatol 1997; 36: 207–209.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D C Kilpatrick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kilpatrick, D., Stewart, K., Allan, E. et al. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 35, 179–181 (2005). https://doi.org/10.1038/sj.bmt.1704746

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704746

Keywords

This article is cited by

Search

Quick links